Billy West
About Billy West
Billy West is the Associate Director of Business Development & Commercial at BenevolentAI, with a PhD in Neuroscience and extensive experience in the pharmaceutical and healthcare industry.
Current Position at BenevolentAI
Billy West is currently serving as the Associate Director of Business Development & Commercial at BenevolentAI. In this role, he is responsible for overseeing business development initiatives and commercial strategies aimed at driving growth and innovation within the company. His work involves collaborating with cross-functional teams to identify new business opportunities, manage client relationships, and contribute to the overall strategic direction of the organization.
Previous Experience in Business Development
Before becoming the Associate Director at BenevolentAI, Billy West worked as a Business Development Executive from 2020 to 2022 at the same company. During his tenure, he played a crucial role in expanding the company's market reach and establishing strong partnerships. His experience in business development was further honed at IQVIA, where he worked as a Consultant from 2018 to 2020 and briefly as a Manager in 2020.
Educational Background in Neuroscience
Billy West has an extensive academic background in neuroscience. He earned his Doctor of Philosophy (PhD) in Neuroscience from University College London, completing his studies from 2011 to 2015. Prior to that, he pursued a Research Year focused on Neurobiology of Addiction at the University of Melbourne from 2009 to 2010. His foundational studies in neuroscience were completed at the University of Nottingham, where he achieved an MSci degree from 2007 to 2011.
Early Career in Life Sciences and Healthcare
West has a demonstrated history of working in the pharmaceutical and healthcare industry. He began his career as a PhD Student at MRC Prion Unit (UCL) from 2011 to 2015. He then transitioned to the industry with roles such as Business Analyst at Lifescience Dynamics Limited in 2015-2016 and Senior Business Analyst in 2016-2017. His consulting experience includes various roles at IQVIA, providing him with a robust foundation in life sciences strategy and patient-centered endpoints.